Saturday 17 October 2026
Export CALC’s income statement to Excel — free account
CalciMedica Inc.
CALC Healthcare Biotechnology
In the quarter to June 2026, EPS fell 12.5%, free cash flow grew 31.4% and total debt rose 8.24%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.07
0.01
−0.93%
Follow CALC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (365.70%) | (399.51%) | (761.02%) | (526.36%) |
+8 more TTM periods Free account |
|
| (110.10%) | (115.11%) | (177.10%) | (148.18%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(132.68%) | (594.95%) | (301.71%) | (205.51%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(5.58) | (6.69) | (7.06) | (7.07) | |
Free Cash Flow |
(19.08) | (21.16) | (21.21) | (21.32) | |
Capital Expenditures |
0.02 | — | (0.03) | (0.02) | |
| Other line items | |||||
Cash ROIC |
(57.25%) | (153.75%) | (131.92%) | (93.86%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(15.16) | (17.18) | (16.26) | (17.72) | |
Operating CF/Net income |
0.90 | 1.08 | 0.72 | 0.92 | |
Depreciation/Fixed assets |
0.86 | 0.88 | 0.92 | 1.12 | |
Capex/Depreciation |
0.74 | 0.00 | (0.61) | (0.44) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(5.59) | (6.69) | (7.05) | (7.06) | |
Capex per Share |
0.01 | 0.00 | (0.01) | (0.01) | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 |
Columns are period end dates